4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-24-019024
CHIEF FINANCIAL OFFICER acquired 3,592 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | 2024-06-28 | Grant or award | +3,592 | $2.96 | $10,625 | 3,592 | D |
Loading xslF345X05/form4-07022024_100748.xml…